Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

New insights into cell communication in psoriasis suggest innovative drug treatments.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Genetics influence opioid addiction risk, diet affects COVID-19 severity, Aerva lanata may harm kidneys, some plants fight fungi and cancer, and nursing students need better contraceptive knowledge.

Understanding proteins linked to PCOS symptoms can improve diagnosis and treatment.

Targeting NETs may help reduce fibrosis in Crohn's disease.

TNF-α inhibitors may cause complete hair loss in some patients with ankylosing spondylitis.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Skin issues can indicate immune system problems.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Baricitinib may effectively treat oral lichen planus.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Immune cells affect hair growth and could lead to new hair loss treatments.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.